Answers are grounded in this paper and cite their sources.
Intestinal amebiasis remains an important cause of gastrointestinal morbidity in children, yet the relationship between inflammasome signaling, gasdermin-mediated inflammation and intestinal barrier disturbance in infected children is poorly characterized. This case-control study evaluated circulating NLR family pyrin domain-containing protein 3 (NLRP3), gasdermin D (GSDMD), interleukin-18 (IL-18) and zonulin in school-aged children with microscopically diagnosed intestinal Entamoeba infection and examined their relationships with clinical severity. The study was conducted at Samarra General Hospital, Iraq, between 10 January and 1 June 2025 and enrolled 120 children aged 7–12 years: 40 with symptomatic infection, 40 with mild or minimally symptomatic infection and 40 healthy controls. Infection was diagnosed by direct saline and Lugol's iodine wet-mount stool microscopy, and serum biomarkers were quantified by sandwich ELISA. All four biomarkers were highest in symptomatic children, intermediate in mildly symptomatic children and lowest in controls (NLRP3: 221.6 ± 61.8 vs 154.2 ± 49.7 vs 103.5 ± 38.4 pg/mL; GSDMD: 302.7 ± 85.3 vs 216.4 ± 72.1 vs 148.9 ± 55.6 pg/mL; IL-18: 66.8 ± 17.5 vs 54.1 ± 16.2 vs 44.6 ± 14.8 pg/mL; zonulin: 557.4 ± 162.8 vs 474.3 ± 151.6 vs 403.8 ± 134.9 pg/mL; all P < 0.001). NLRP3 correlated with GSDMD (ρ = 0.58), IL-18 (ρ = 0.44) and zonulin (ρ = 0.31; all P < 0.001), and all markers correlated with the clinical severity score and daily stool frequency. NLRP3 and GSDMD best discriminated symptomatic children from controls (AUC 0.87 and 0.85), and a combined four-marker model reached an AUC of 0.91 (sensitivity 85.0%, specificity 87.5%). In multivariable analysis, NLRP3 (adjusted OR 2.46, 95% CI 1.38–4.39) and GSDMD (adjusted OR 1.91, 95% CI 1.12–3.25) remained independently associated with symptomatic infection. Symptomatic childhood amebiasis is therefore accompanied by a graded increase in circulating inflammasome–gasdermin markers that tracks clinical severity and covaries with barrier-associated zonulin, supporting a coupled model of mucosal inflammatory signaling and intestinal barrier disturbance.
No takes yet. Share an insight, caveat, or question.
shihab ahmed mutlak (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: